Package Label-principal Display Panel (10 mg/12.5 mg (100 Tablet Bottle))
Fosinopril Sodium And Hydrochlorothiazide Tablet
Product Images NDC 65862-309
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium And Hydrochlorothiazide (NDC 65862-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (20 mg/12.5 mg (100 Tablet Bottle))
This is a description of a medication called "Fosinopril Sodium and Hydrochlorothiazide Tablets, USP" which contains 20mg/12.5mg of fosinopril sodium and hydrochlorothiazide respectively. The text indicates that the medication is made in India and provides the usual dosage. It also recommends to store the medication at a temperature between 20°C to 25°C and to keep the bottle tightly closed to protect it from moisture. Additionally, there is a product code provided: DG 65862-309-01.*
Fosinopril Sodium Chemical Structure (Fosinoprilhctz Str1)
Hydrochlorothiazide Chemical Structure (Fosinoprilhctz Str2)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
